mechlorethamine and arginine

mechlorethamine has been researched along with arginine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19906 (60.00)18.7374
1990's3 (30.00)18.2507
2000's0 (0.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ellenberger, J; Mohn, G1
Schjelderup, A; Smith-Kielland, I; Zarins, P1
FUJII, M; HANO, S; ISHII, H; IWATA, S; KAGEYAMA, T; KURISU, T; TSUTSUMI, T; WADA, M; WAKABAYASHI, A1
Grieder, A; Maurer, R; Stähelin, H1
Boyce, RA; Hertzberg, RP; Mattern, MR; Schein, PS; Tan, KB1
Burgers, JM; Dekker, AW; Kazem, I; Kroese, WF; Qasim, MM; Sizoo, W; Somers, R; van Peperzeel, HA; Wagener, DJ1
Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U1
Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M1
Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE1

Reviews

1 review(s) available for mechlorethamine and arginine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for mechlorethamine and arginine

ArticleYear
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine

1994
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine

1995

Other Studies

7 other study(ies) available for mechlorethamine and arginine

ArticleYear
Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.
    Archives of toxicology, 1975, Volume: 33, Issue:3

    Topics: Animals; Arginine; Biotransformation; Cyclophosphamide; Escherichia coli; Female; Galactose; Genes; Histidine; Ifosfamide; Liver; Mechlorethamine; Mice; Mice, Inbred Strains; Mutagens; Operon; Rats; Rats, Inbred Strains; Salmonella typhimurium; Tryptophan

1975
Repair replication in different strains of Escherichia coli after treatment with alkylating agents and its dependence on protein synthesis.
    Biochimica et biophysica acta, 1972, Mar-24, Volume: 262, Issue:3

    Topics: Alkylating Agents; Arginine; Chloramphenicol; DNA Repair; DNA Replication; DNA, Bacterial; Escherichia coli; Genetics, Microbial; Isotope Labeling; Kinetics; Mechlorethamine; Mitomycins; Mutation; Species Specificity; Thymidine; Tritium

1972
[CLINICAL AND EXPERIMENTAL STUDIES ON CHANGES IN THE BODY FLUIDS IN CANCER].
    [Nisshin igaku] The Japanese journal of medical progress, 1963, Volume: 50

    Topics: Antineoplastic Agents; Arginine; Ascites; Aspartate Aminotransferases; Blood Chemical Analysis; Blood Proteins; Body Fluids; Cyclophosphamide; Glycoproteins; Mechlorethamine; Mitomycin; Mitomycins; Neoplasms; Neuraminic Acids; Pharmacology; Polarography; Rats; Research; Thiotepa

1963
Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
    Cancer research, 1977, Volume: 37, Issue:9

    Topics: Antineoplastic Agents; Bleomycin; Cell Division; Cell Line; Colchicine; Cytarabine; DNA, Neoplasm; Etoposide; Mast-Cell Sarcoma; Mechlorethamine; Mercaptopurine; Methotrexate; Mitosis; Neoplasm Proteins; Neoplasms, Experimental; Podophyllotoxin; Razoxane; RNA, Neoplasm; Teniposide; Vincristine; X-Rays

1977
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
    NCI monographs : a publication of the National Cancer Institute, 1987, Issue:4

    Topics: Amsacrine; Burkitt Lymphoma; Cell Line; Cell Survival; Chromatin; DNA Topoisomerases, Type II; Drug Resistance; Humans; Kinetics; Mechlorethamine; Novobiocin; Podophyllotoxin; Teniposide; Tumor Stem Cell Assay

1987
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
    Cancer, 1983, Nov-01, Volume: 52, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Europe; Female; Hodgkin Disease; Humans; Leukopenia; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Radiotherapy; Recurrence; Teniposide; Vincristine

1983
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:5

    Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Control Studies; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Risk Factors; Teniposide

1994